What Has Been The Evolution of the Small Volume Parenteral Market in Recent Years?
The small volume parenteral market has seen considerable growth due to a variety of factors.
• The small volume parenteral market has experienced strong growth in recent years. It will rise from $177.26 billion in 2024 to $193.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%.
The historic growth is attributed to the increasing prevalence of chronic diseases, regulatory approvals, government initiatives, pharmaceutical outsourcing trends, and global pharmaceutical market expansion.
How Will the Small Volume Parenteral Market?
The small volume parenteral market is expected to maintain its strong growth trajectory in upcoming years.
• The small volume parenteral market is expected to grow strongly, reaching $268.53 billion by 2029 at a CAGR of 8.6%.
Factors driving growth include the expansion of the biologics market, healthcare infrastructure development, increasing hospitalization, regulatory approvals, a shift toward home healthcare, and rising healthcare investments. Trends include biocompatible formulations, patient-centric approaches, home healthcare expansion, manufacturing automation, and smart pump technologies.
Which Factors Are Boosting Growth In The Small Volume Parenteral Market?
The growth of the small-volume parenteral market is being fuelled by the rising number of surgeries. A specialty in medicine, surgery employs operative measures to diagnose or attend to pathological issues like disease or injury, enhancing bodily functionality or aesthetics, and mending unwanted ruptured areas. With developments in medical science and an aging population, surgery rates are on the rise, escalating the need for surgical interventions. Small-volume parenteral solutions are utilized during these procedures to accurately deliver medications, electrolytes, and nutrients straight into the bloodstream. For example, data from The Aesthetic Society, an American body encompassing plastic surgery and cosmetic medicine, reveals that in August 2023 alone, Americans lavished over $11.8 billion on aesthetic procedures in total, which saw a 2% rise from the preceding year. As such, the surge in surgical operations is supporting the expansion of the small-volume parenteral market.
What Key Areas Define The Segmentation Of The Global Small Volume Parenteral Market?
The small volume parenteral market covered in this report is segmented –
1) By Type: Ampules, Vials, Prefilled Syringes
2) By Dose Type: Single Dose, Multiple Dose
3) By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications
4) By Application: Local Anesthetics, Vaccines, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Center, Other End Users
Subsegments:
1) By Ampules: Glass Ampules, Plastic Ampules
2) By Vials: Glass Vials, Plastic Vials, Single-dose Vials, Multi-dose Vials
3) By Prefilled Syringes: Glass Prefilled Syringes, Plastic Prefilled Syringes
Pre-Book The Small Volume Parenteral Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Small Volume Parenteral Market?
Leading businesses in the small volume parenteral market are prioritizing the development of novel solutions, such as integrated lyophilizers, to boost their market revenues. An integrated lyophilizer is a system incorporated into the production line that freezes and dehydrates products to produce lyophilized powders, typically used for specific parenteral drugs. For instance, WuXi STA, a pharmaceutical firm based in China, introduced a new parenteral formulation manufacturing line in January 2022. This new production line, together with the sterile manufacturing facility in Wuxi, is built in compliance with cGMP rules established by the U.S. FDA, EMA, and China NMPA. It boasts the most recent isolation systems and filling machinery in the sector. The entire filling operation is robotically managed within a completely isolated setting, specifically constructed to minimize human interaction and eradicate contamination, thereby guaranteeing exceptional product quality.
Who Are the Key Players In The Small Volume Parenteral Market?
Major companies operating in the small volume parenteral market are:
• Pfizer Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• GlaxoSmithKline plc
• Eli Lilly and Company
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Fresenius Kabi AG
• Sun Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Viatris Inc.
• Intas Pharmaceuticals Ltd.
• Aurobindo Pharma Limited
• Dr. Reddy’s Laboratories Ltd.
• Cipla Limited
• Hikma Pharmaceuticals PLC
• Lupin Limited
• Biocon Limited
• Torrent Pharmaceuticals Ltd.
• Zydus Cadila
• Alembic Pharmaceuticals Ltd.
• Wockhardt Ltd.
What Is The Most Dominant Region In The Small Volume Parenteral Market?
North America was the largest region in the small volume parenteral market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the small volume parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
